Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.60 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.60 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.60 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 2/20 | 0.55 |
| ▸ | MIF | P14174 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | GLA | P06280 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30151888 | 0.86 | SHBG (0.57) | SHBGPTGS1TYRPTGS2PDE4B | |
| SCHEMBL9138143 | 0.80 | SHBG (1.00) | SHBGPTGS1TYRPTGS2PDE4B | |
| SCHEMBL307532 | 0.80 | EGFR (0.47) | SHBGAPPKDM4EALDH1A1HPGD | |
| SCHEMBL223274 | 0.77 | PTPRC (0.59) | TYRESR2KDM4EALDH1A1HPGD | |
| SCHEMBL29791652 | 0.77 | PTPRC (0.59) | TYRESR2KDM4EALDH1A1HPGD | |
| SCHEMBL5656896 | 0.77 | KDM4E (0.49) | SHBGAPPKDM4EALDH1A1HPGD | |
| SCHEMBL28348664 | 0.76 | PTPRC (0.58) | TYRESR2KDM4EALDH1A1HPGD | |
| Moracin M SCHEMBL29979946 | 0.75 | PDE4D (1.00) | SHBGPTGS1TYRPTGS2PDE4B | |
| Moracin M SCHEMBL1740981 | 0.75 | PDE4D (1.00) | SHBGPTGS1TYRPTGS2PDE4B | |
| SCHEMBL733973 | 0.75 | SHBG (0.80) | SHBGPTGS1TYRPTGS2PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264603-A1 | THERMAL MANAGEMENT FLUID COMPOSITIONS CONTAINING RECLAIMED MATERIALS | THE CHEMOURS COMPANY FC, LLC (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250066653-A1 | FLUOROOLEFIN COMPOSITIONS CONTAINING A DYE AND METHODS FOR THEIR PRODUCTION, STORAGE AND USAGE | THE CHEMOURS COMPANY FC, LLC (US) | 2025-02-27 | — | — | US | claimed |
| EP-4466323-A1 | FLUOROOLEFIN COMPOSITIONS CONTAINING A DYE AND METHODS FOR THEIR PRODUCTION, STORAGE AND USAGE | The Chemours Company FC, LLC (US) | 2024-11-27 | — | — | EP | claimed |
| CN-118302501-A | Fluoroolefin compositions containing dyes and methods of making, storing and using same | 科慕埃弗西有限公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2023141098-A1 | FLUOROOLEFIN COMPOSITIONS CONTAINING A DYE AND METHODS FOR THEIR PRODUCTION, STORAGE AND USAGE | THE CHEMOURS COMPANY FC, LLC (US) | 2023-07-27 | — | — | WO | claimed |
| US-6962992-B2 | Crown ether derivatives for use in enhancing transfer of indicators into viabile cells | MOLECULLAR PROBES, INC. (US) | 2005-11-08 | — | — | US | claimed |
| US-20020164616-A1 | Crown ether derivatives | MOLECULAR PROBES, INC. (US) | 2002-11-07 | — | — | US | claimed |
| EP-4684338-A1 | SYSTEMS AND METHODS OF RECLAMATION OF THERMAL MANAGEMENT FLUIDS | The Chemours Company FC, LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| WO-2025264603-A1 | THERMAL MANAGEMENT FLUID COMPOSITIONS CONTAINING RECLAIMED MATERIALS | THE CHEMOURS COMPANY FC, LLC (US) | 2025-12-26 | — | — | WO | disclosed |
| US-12487180-B2 | Device and methods for quantifying analytes introduction | Life Technologies Corporation (US) | 2025-12-02 | — | — | US | disclosed |
| EP-4633458-A1 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | Adaptyx Biosciences, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4565237-A1 | PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR THE TREATMENT OF GLIOMA | Chimerix, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| CN-119997956-A | Pharmaceutical composition and use thereof for treating glioma | 奇默里克斯公司 | 2025-05-13 | — | — | CN | disclosed |
| US-6162931-A | Fluorinated xanthene derivatives | MOLECULAR PROBES, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| US-6130101-A | FLUORESCENT PROBES FOR USE IN BIOLOGICAL SAMPLES | MOLECULAR PROBES, INC. (US) | 2000-10-10 | — | — | US | disclosed |
| EP-0853647-A1 | FLUORINATED XANTHENE DERIVATIVES | Molecular Probes Inc. (US) | 1998-07-22 | — | — | EP | disclosed |
| WO-1997039064-A1 | FLUORINATED XANTHENE DERIVATIVES | MOLECULAR PROBES, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| US-4652531-A | Fluorescent protein binding assays with unsymmetrical fluorescein derivatives | SYNTEX (U.S.A.) INC. (US) | 1987-03-24 | — | — | US | disclosed |
| EP-0141962-A1 | Hydrazine derivatives of fluorans and use thereof in electrochromic recording systems | THE HILTON - DAVIS CHEMICAL COMPANY (US) | 1985-05-22 | — | — | EP | disclosed |
| US-4439356-A | XANTHENES, IMMUNOASSAY | SYVA COMPANY (US) | 1984-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020164616-A1 | Crown ether derivatives | CD2, SLC40A1, NCOA1 | SHBG 1868/4885PTGS1 1738/4885TYR 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.